Brainstorm Cell Therapeutics Inc. (BCLI) SEC Filings — 2025
17 SEC filings for Brainstorm Cell Therapeutics Inc. (BCLI) in 2025.
Filings
- Brainstorm's Losses Narrow, But Nasdaq Delisting Raises Red Flags — 10-Q · Nov 14, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Nov 6, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Aug 14, 2025
- Brainstorm Delisted from Nasdaq, Losses Mount Amid R&D Push — 10-Q · Aug 14, 2025
- Brainstorm Cell Therapeutics Faces Delisting Concerns — 8-K · Jul 17, 2025
- Brainstorm Cell Therapeutics Files 8-K on Officer Changes & Shareholder Votes — 8-K · Jun 25, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Jun 16, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · May 19, 2025
- Brainstorm Cell Therapeutics Proxy Statement Filed — DEF 14A · May 16, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · May 15, 2025
- Brainstorm Cell Therapeutics Q1 2025 Financials Released — 10-Q · May 15, 2025
- Brainstorm Cell Therapeutics Files 8-K — 8-K · Apr 21, 2025
- Brainstorm Cell Therapeutics Files 8-K with Key Agreements — 8-K · Mar 31, 2025
- Brainstorm Cell Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
- Brainstorm Cell Therapeutics Updates Fiscal Year End — 8-K · Mar 27, 2025
- Brainstorm Cell Therapeutics Faces Delisting Concerns — 8-K · Jan 21, 2025
- Brainstorm Cell Therapeutics Faces Delisting Notice — 8-K · Jan 15, 2025